0001127602-19-007865.txt : 20190225 0001127602-19-007865.hdr.sgml : 20190225 20190225093613 ACCESSION NUMBER: 0001127602-19-007865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150210 FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ellingwood Dwight E CENTRAL INDEX KEY: 0001614529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 19628253 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2015-02-10 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001614529 Ellingwood Dwight E 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 Common Stock 2015-02-10 4 P 0 33 18.1998 A 3013 D Common Stock 2015-05-11 4 P 0 32 18.5148 A 3045 D Common Stock 2015-08-10 4 P 0 32 18.6911 A 3077 D Common Stock 2015-11-23 4 P 0 32 19.2658 A 3109 D Common Stock 2016-02-12 4 P 0 32 19.6196 A 3141 D Common Stock 2016-05-16 4 P 0 33 19.0604 A 3174 D Common Stock 2016-08-15 4 P 0 32 19.5009 A 6206 D Common Stock 2016-11-28 4 P 0 38 17.065 A 6244 D Common Stock 2017-02-13 4 P 0 41 12.9286 A 7305 D Common Stock 2017-05-15 4 P 0 36 14.8972 A 7341 D Common Stock 2017-08-14 4 P 0 39 13.938 A 7380 D Common Stock 2017-11-28 4 P 0 38 14.5607 A 7418 D Common Stock 2018-02-13 4 P 0 39 14.1311 A 7457 D Common Stock 2018-05-15 4 P 0 40 13.8794 A 7497 D Common Stock 2018-08-16 4 P 0 38 14.9125 A 7535 D Common Stock 2018-11-28 4 P 0 31 18.4216 A 8566 D Common Stock 2019-02-21 4 J 0 981 0 D 0 D Common Stock 2019-02-21 4 J 0 981 0 A 9547 D Share purchases reflected on this Form were acquired via a Dividend Reinvestment Plan ("DRIP") beginning in February 2015 and ceasing in November 2018. Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Common Stock holdings currently total 9,547. /s/ Bryan T. Baldasare as Attorney-in-Fact for Dwight Ellingwood 2019-02-25